Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis
Open accessThe DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Neuromuscular junction assembly and plasticity during embryonic, postnatal, and adult life are tightly regulated by the continuous cross-talk among motor nerve endings, muscle fibers, and glial cells. Altered communications among these components is thought to be responsible for the physiological age-related changes at this synapse and possibly for its destruction in pathological states. Neuromuscular junction dismantling plays a crucial role in the onset of Amyotrophic Lateral Sclerosis (ALS). ALS is characterized by the degeneration and death of motor neurons leading to skeletal muscle denervation, atrophy and, most often, death of the patient within five years from diagnosis. ALS is a non-cell autonomous disease as, besides motor neuron degeneration, glial cells, and possibly muscle fibers, play a role in its onset and progression. Here, we will review the recent literature regarding the mechanisms leading to neuromuscular junction disassembly and muscle denervation focusing on the role of the three players of this peripheral tripartite synapse.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition, neuromuscular junction dismantling and denervation occur in aged muscle, which are also key factors contributing to the onset of clinical symptoms and pathogenesis of ALS.293”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [293]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062 · cited 1×
“In 1993, a landmark discovery of 11 missense mutations in the SOD1 gene, in 13 fALS families [47], heralded the genetic age for ALS.”
BackgroundProtein aggregation and neurodegenerative disease
Ross, C. A., & Poirier, M. A. (2004) · Nature Medicine · doi:10.1038/nm1066 · Cited by 3,454
Tripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529 · cited 1×
“It was shown that they were able to respond to neuronal activity by increasing their intracellular Ca2+ concentration [1] and releasing chemical gliotransmitters (i.”
BackgroundOnset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623 · cited 1×
“The pathogenic role of mutant SOD1 expression in microglia has been equally investigated and, also in this case, it was show that by downregulating SOD1 levels in microglial cells in vivo increased the mean survival of the mutant mice by slowing disease progression after onset [101,102].”
BackgroundState of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544 · cited 1×
“The progressive failure of the neuromuscular system results in weakness and atrophy of the limb musculature, gradual paralysis, and death from respiratory failure typically within two to three years of symptom onset [34].”
BackgroundAmyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,357 · cited 1×
“, through glutamate excitotoxicity or altered neuronal excitability) and then extend in an anterograde fashion to corticospinal projections [61], or if ALS has to be considered a distal axonopathy in which motor neuron degeneration starts at the nerve endings and progress toward the cell bodies in a dying back manner…”
BackgroundGliotransmitters Travel in Time and Space
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H. R., Robitaille, R., & Volterra, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.007 · Cited by 1,308
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
Yamanaka, K., Chun, S. J., Boillee, S., Fujimori-Tonou, N., Yamashita, H., Gutmann, D. H., Takahashi, R., Misawa, H., & Cleveland, D. W. (2008) · Nature Neuroscience · doi:10.1038/nn2047 · Cited by 1,140 · cited 1×
“On the other hand, it was shown that these cells played a relevant role in modulating ALS progression, since delayed microglial activation and slowed disease progression in SOD1 mice were observed [97,98] by reducing their level of expression of mutant SOD1.”
BackgroundWild-Type Nonneuronal Cells Extend Survival of SOD1 Mutant Motor Neurons in ALS Mice
Clement, A. M., Nguyen, M. D., Roberts, E. A., Garcia, M. L., Boillée, S., Rule, M., McMahon, A. P., Doucette, W., Siwek, D., Ferrante, R. J., et al. (2003) · Science · doi:10.1126/science.1086071 · Cited by 1,100 · cited 1×
“This observation was confirmed by the generation of chimeric mice where it was shown that, in the absence of mutant SOD1 expression in non-neuronal cells, mutant SOD1 in neurons was not toxic in itself [67].”
Background
Cited by
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“293 In addition, a well-recognized observation in HD patients is defects in energy metabolism in skeletal muscle. mHTT affects mitochondrial complex activation and dysfunction of the mitochondrial respiratory chain in skeletal muscle, which may be markers of HD progression.”
3D bioprinting of complex tissues in vitro: state-of-the-art and future perspectives
Xiang, Y., Miller, K. L., Guan, J., Kiratitanaporn, W., Tang, M., & Chen, S. (2022) · Archives of Toxicology · doi:10.1007/s00204-021-03212-y · Cited by 105
“2014, Cappello and Francolini 2017).”
Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
Pandya, V. A., & Patani, R. (2020) · Brain · doi:10.1093/brain/awz360 · Cited by 86
Tissue-Engineered Skeletal Muscle Models to Study Muscle Function, Plasticity, and Disease
Khodabukus, A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.619710 · Cited by 97
“Importantly, the use of hiPSCs allows the modeling of multiple human neuromuscular disease such as MG, spinal muscular atrophy (SMA), and ALS which would not be possible due to the post-mitotic state of adult motor neurons (Dimos et al., 2008; Ebert et al., 2009; Sances et al., 2016).”
BackgroundLoss of mouse Stmn2 function causes motor neuropathy
Juan, I. G. S., Nash, L. A., Smith, K. S., Leyton-Jaimes, M. F., Qian, M., Klim, J. R., Limone, F., Dorr, A. B., Couto, A., Pintacuda, G., et al. (2022) · Neuron · doi:10.1016/j.neuron.2022.02.011 · Cited by 92
Mechanisms of exercise as a preventative measure to muscle wasting
Graham, Z., Lavin, K. M., O’Bryan, S. M., Thalacker‐Mercer, A. E., Buford, T. W., Ford, K. M., Broderick, T. J., & Bamman, M. M. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00056.2021 · Cited by 93
A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
Vijayakumar, U. G., Milla, V., Stafford, M. Y. C., Bjourson, A. J., Duddy, W. J., & Duguez, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00400 · Cited by 74
“In these cases, it is likely a combination of these factors that leads to cellular dysfunction such as glutamatemediated excitotoxicity (24), abnormal protein aggregation (25), mitochondrial disorganization and dysfunction (26, 27) contributing to the oxidative stress (28–30) (Figure 2).”
BackgroundLeng, Y., Li, X., Zheng, F., Liu, H., Wang, C., Wang, X., Liao, Y., Liu, J., Meng, K., Yu, J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202211059 · Cited by 63
Adaptive Remodeling of the Neuromuscular Junction with Aging
Deschenes, M. R., Flannery, R. E., Hawbaker, A., Patek, L. G., & Mifsud, M. (2022) · Cells · doi:10.3390/cells11071150 · Cited by 68
de Jongh, R., Spijkers, X. M., Pasteuning-Vuhman, S., Vulto, P., & Pasterkamp, R. J. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15289 · Cited by 69
“NMJ defects are detected pre-symptomatically in experimental ALS and lead to axon retraction and motor neuron degeneration (Cappello & Francolini, 2017).”
BackgroundKarim, A., Iqbal, M. S., Muhammad, T., Ahmad, F., & Qaisar, R. (2022) · Neuroscience Research · doi:10.1016/j.neures.2022.08.004 · Cited by 59
Destination Amyotrophic Lateral Sclerosis
Keon, M., Musrie, B., Dinger, M. E., Brennan, S. E., Santos, J., & Saksena, N. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.596006 · Cited by 64
“The cells that surround the NMJ play vital roles in modulating the strength of neurotransmission with muscle fibers, remodeling of NMJ, and post-injury repair (45).”
BackgroundInfluentialSarcopenia – Endocrinological and Neurological Aspects
Stangl, M. K., Böcker, W., Chubanov, V., Ferrari, U., Fischereder, M., Gudermann, T. W., Hesse, E., Meinke, P., Reincke, M., Reisch, N., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-1007 · Cited by 67
“There is clinical and animal experimental debate that pathological changes might occur at the neuromuscular junction (NMJ) prior to motor neuron degeneration and onset of clinical symptoms [75].”
Martin, L. J., & Wong, M. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.592851 · Cited by 53
Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles
Gall, L. L., Duddy, W. J., Martinat, C., Mariot, V., Connolly, O., Milla, V., Anakor, E., Ouandaogo, Z. G., Millecamps, S., Lainé, J., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12945 · Cited by 52
“Not only motor neurons (MN) are affected in ALS, but also glial cells, muscle fi bres, 4 and immune cells, 5 each of which may participate actively in ALS onset and progression.”
Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
Shah, S., Dooms, M. M., Amaral‐Garcia, S., & Igoillo‐Esteve, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768023 · Cited by 55
Drug Repurposing: A Network-based Approach to Amyotrophic Lateral Sclerosis
Fiscon, G., Conte, F., Amadio, S., Volonté, C., & Paci, P. (2021) · Neurotherapeutics · doi:10.1007/s13311-021-01064-z · Cited by 49
“brainstem, and spinal cord [3–5]; defects in neuromuscular junctions causing disassembling and denervation of skeletal muscle [6]; and gradual muscle atrophy leading to strength reduction and alteration of the contractile apparatus [7].”
BackgroundSen, T., & Thummer, R. P. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00564-w · Cited by 55
“There is a growing body of evidence that indicates the need to consider muscle fibers alongside motor neurons as well as their functional interface, i.e., the NMJ, as important players in ALS initiation, progression, and therapy (Cappello and Francolini 2017; Jongh et al.”
BackgroundMethodDiagnostic Challenge and Neuromuscular Junction Contribution to ALS Pathogenesis
Campanari, M., Bourefis, A.-R., & Kabashi, E. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00068 · Cited by 51
“Nonetheless, increasing evidence points to the critical role of NMJ defects in the early stage of the disease in ALS patients [reviewed in (21)] and a variety of animal models have permitted important advances into exploring this hypothesis.”
BackgroundThe Skeletal Muscle Emerges as a New Disease Target in Amyotrophic Lateral Sclerosis
Pikatza‐Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz‐Gastesi, N., de Munaín, A. L., Gereñu, G., Gil-Bea, F. J., & Alonso‐Martín, S. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11070671 · Cited by 51
“However, the resulting denervation is not only due to the impossibility of successful MN sprouting but also impaired TSC process extension that leads to insufficient re-occupation of denervated synaptic sites [97,295,299].”
BackgroundMultiple Roles of Transforming Growth Factor Beta in Amyotrophic Lateral Sclerosis
Galbiati, M., Crippa, V., Rusmini, P., Cristofani, R., Messi, E., Piccolella, M., Tedesco, B., Ferrari, V., Casarotto, E., Chierichetti, M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124291 · Cited by 48
“On the other hand, at the level of the skeletal muscle, the chronically increased TGFB signaling facilitates the development of atrophy and fibrosis in skeletal muscle fiber, and the process of NMJ dismantling.”
BackgroundInfluentialTerminal Schwann Cell Aging: Implications for Age-Associated Neuromuscular Dysfunction
Fuertes-Álvarez, S., & Izeta, A. (2021) · Aging and Disease · doi:10.14336/ad.2020.0708 · Cited by 51
A Human‐Based Functional NMJ System for Personalized ALS Modeling and Drug Testing
Guo, X., Smith, V., Jackson, M., Tran, M., Thomas, M., Patel, A., LoRusso, E., Nimbalkar, S., Cai, Y., McAleer, C. W., et al. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000133 · Cited by 47
Badu-Mensah, A., Guo, X., McAleer, C. W., Rumsey, J. W., & Hickman, J. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-70510-3 · Cited by 39
Baskoylu, S., Chapkis, N., Unsal, B., Lins, J., Schuch, K. N., Simon, J., & Hart, A. C. (2022) · Cell Reports · doi:10.1016/j.celrep.2021.110195 · Cited by 39
Lynch, E. M., Semrad, T., Belsito, V. S., FitzGibbons, C., Reilly, M. L., Hayakawa, K., & Suzuki, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039552 · Cited by 38
“Cross-talk between skeletal muscle and an adjacent motor neuron is a critical component of NMJ formation during development, and a continued part of NMJ maintenance (Cappello and Francolini, 2017).”
Amyotrophic Lateral Sclerosis Genes in Drosophila melanogaster
Layalle, S., They, L., Ourghani, S., Raoul, C., & Soustelle, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020904 · Cited by 37
“ALS is characterized by the progressive dismantling of the neuromuscular junctions and degeneration of motoneurons in the brain and spinal cord [7,8].”
BackgroundZhao, J., Cooper, L. T., Boyd, A., & Bartlett, P. F. (2018) · Scientific Reports · doi:10.1038/s41598-018-29845-1 · Cited by 36
Engineering complex muscle-tissue interfaces through microfabrication
Arrigoni, C., Petta, D., Bersini, S., Mironov, V., Candrian, C., & Moretti, M. (2019) · Biofabrication · doi:10.1088/1758-5090/ab1e7c · Cited by 35
Molecular hallmarks of ageing in amyotrophic lateral sclerosis
Jagaraj, C. J., Shadfar, S., Kashani, S. A., Saravanabavan, S., Farzana, F., & Atkin, J. D. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05164-9 · Cited by 42
Verde, E. M., Secco, V., Ghezzi, A., Mandrioli, J., & Carra, S. (2025) · Cells · doi:10.3390/cells14100680 · Cited by 38
Thrombin and the Coag-Inflammatory Nexus in Neurotrauma, ALS, and Other Neurodegenerative Disorders
Festoff, B. W., & Citron, B. A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00059 · Cited by 34
NMJ-Analyser identifies subtle early changes in mouse models of neuromuscular disease
Maza, A. M., Jarvis, S., Lee, W. C., Cunningham, T. J., Schiavo, G., Secrier, M., Fratta, P., Sleigh, J. N., Fisher, E., & Sudre, C. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-91094-6 · Cited by 34
“Two fundamental questions in neuromuscular disease remain unsolved: (1) do the pre- or postsynaptic NMJ components degenerate in a synchronised manner in ALS? and (2) does the skeletal muscle drive NMJ destruction? To validate NMJ-Analyser and to gain new insight into neuromuscular degeneration, we assessed individual…”
BackgroundNAD+ Metabolism and Diseases with Motor Dysfunction
Lundt, S., & Ding, S. (2021) · Genes · doi:10.3390/genes12111776 · Cited by 28
“not been determined yet, though mitochondrial dysfunction, oxidative stress, and neuroinflammation, along with other impairments, have been observed in ALS and are being investigated [86,87].”
BackgroundDuranti, E., & Villa, C. (2023) · Biomolecules · doi:10.3390/biom13111582 · Cited by 31
“Notably, TSCs in ALS cases exhibit abnormal morphology and impaired sprouting abilities [88–90 , 93 ].”
BackgroundKubat, G. B., & Picone, P. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07508-6 · Cited by 33
“ALS is associated with a gradual deterioration of NMJ integrity, which is linked to changes in the function and quantity of SCs [56, 57] (Fig.”
BackgroundLimitations and Challenges in Modeling Diseases Involving Spinal Motor Neuron Degeneration in Vitro
Bucchia, M., Merwin, S. J., Ré, D. B., & Kariya, S. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00061 · Cited by 34
“This concept would also apply for the in vitro modeling of ALS, whose central pathology primarily arises from degeneration of settled MNs (Cappello and Francolini, 2017).”
BackgroundWilliamson, M. G., Finelli, M. J., Sleigh, J. N., Reddington, A., Gordon, D., Talbot, K., Davies, K. E., & Oliver, P. L. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz190 · Cited by 34
Giagnorio, E., Malacarne, C., Mantegazza, R., Bonanno, S., & Marcuzzo, S. (2021) · Journal of Cell Science · doi:10.1242/jcs.258349 · Cited by 24
Badu-Mensah, A., Guo, X., Nimbalkar, S., Cai, Y., & Hickman, J. J. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121752 · Cited by 28
Arjmand, B., Hamidpour, S. K., Rabbani, Z. H., Tayanloo-Beik, A., Rahim, F., Aghayan, H. R., & Larijani, B. A. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2021.788462 · Cited by 29
Zou, S., & Pan, B. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00829-z · Cited by 24
“And noticed that NMJ alterations were the early onset of the clinical symptoms [145], a dying-back hypothesis in ALS pathogenesis was proposed that NMJ dismantling plays a crucial role in starting ALS [120, 141].”
BackgroundInfluentialSynucleinopathy in Amyotrophic Lateral Sclerosis: A Potential Avenue for Antisense Therapeutics?
Roberts, B., Theunissen, F., Mastaglia, F. L., Akkari, P. A., & Flynn, L. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169364 · Cited by 25
“Progressive loss of motor neurons and muscle innervation results in severe muscle atrophy, weakness, and paralysis in ALS patients [4].”
BackgroundA Review of Biomarkers of Amyotrophic Lateral Sclerosis: A Pathophysiologic Approach
Alshehri, R. S., Abuzinadah, A. R., Alrawaili, M. S., Alotaibi, M. K., Alsufyani, H. A., Alshanketi, R. M., & Alshareef, A. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010900 · Cited by 26
“Defective acetylcholine (Ach) handling in presynaptic terminals likely contributes to the degeneration of distal axons [32].”
BackgroundInfluentialPolyamine metabolism dysregulation contributes to muscle fiber vulnerability in ALS
Ruggieri, V., Scaricamazza, S., Bracaglia, A., D’Ercole, C., Parisi, C., D’Angelo, P., Proietti, D., Cappelletti, C., Macone, A., Lozanoska‐Ochser, B., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.115123 · Cited by 22
Curzio, D. L. D., Gurm, M., Turnbull, M., Nadeau, M.-J., Meek, B., Rempel, J. D., Fineblit, S., Jonasson, M. E., Hebert, S., Ferguson-Parry, J., et al. (2020) · Cells · doi:10.3390/cells9071584 · Cited by 22
MG53 Preserves Neuromuscular Junction Integrity and Alleviates ALS Disease Progression
Yi, J., Li, A., Li, X., Park, K. H., Zhou, X., Yi, F., Xiao, Y., Yoon, D., Tan, T., Ostrow, L. W., et al. (2021) · Antioxidants · doi:10.3390/antiox10101522 · Cited by 21
“Both sporadic ALS (sALS) and familial ALS (fALS) patients show remarkable mitochondrial defects in motor neuron and skeletal muscle [50–55] and in NMJ degeneration [56,57].”
BackgroundXing, G., Jing, H., Zheng, Y., Chen, P., Wang, H., Xiong, W., & Mei, L. (2021) · Neuron · doi:10.1016/j.neuron.2021.04.021 · Cited by 24
McIntosh, J., Mekrouda, I., Dashti, M., Giuraniuc, C. V., Banks, R. W., Miles, G. B., & Bewick, G. S. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1169075 · Cited by 23
“First, a shortage of vesicles available for release, due to a reduced vesicle density (Cappello and Francolini, 2017) and, second, shortage of ATP, since mitochondria show increased pathology at all stages in disease in hSOD1-G93A mice (Rogers et al.”
BackgroundMohamed, A. A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01243 · Cited by 17
“…are normal in patients with MNDs, several studies have demonstrated that patients with MNDs experience abnormalities in the neuromuscular transmission, and mitochondrial function (Bowling et al., 1993; Dupuis et al., 2005; Rocha et al., 2013; Cappello and Francolini, 2017; Vandoorne et al., 2018).”
BackgroundSkeletal muscle, neuromuscular organoids and assembloids: a scoping review
Yang, J.-L., Qian, S.-Y., Chen, M.-L., Wang, L., Wang, Y., Liu, J., Xi, C., Yang, Y., Li, Y., Gao, C., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105825 · Cited by 21
“53 The NMOs exhibited nerve-dependent muscle contraction, which was blocked by curare, confirming that the activity was reliant on functional NMJs. Additionally, the organoids developed a spinal network resembling central pattern generator circuits, which are essential for rhythmic motor functions…”
Motanova, E. S., Sarto, F., Negro, S., Pirazzini, M., Rossetto, O., Rigoni, M., Stashuk, D. W., Gasparini, M., Šimunič, B., Pišot, R., et al. (2025) · The Journal of Physiology · doi:10.1113/jp288448 · Cited by 16
“Alterations at this synapse are implicated in a variety of neuromuscular disorders (Bruneteau et al., 2015; Cappello & Francolini, 2017; Navarro-Martínez et al., 2023; Verma et al., 2022) and in the context of ageing (Arnold & Clark, 2023; Deschenes & Wilson, 2003; Deschenes et al., 2022; Iyer E.…”
Banerjee, S., Benji, S., Liberow, S., & Steinhauer, J. (2020) · Genetics · doi:10.1534/genetics.120.303495 · Cited by 17
Lee, S. Y., Cho, H.-Y., Oh, J.-P., Park, J., Bae, S.-H., Park, H., Kim, E. J., & Lee, J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01444-7 · Cited by 21
“At the motor neuron level, deficits occur in the neuromuscular junction (NMJ) [12, 13], axons [14, 15], mitochondria [16–18], and/or the cell nucleus [19].”
BackgroundLuan, T., Li, Q., Huang, Z., Feng, Y., Xu, D., Zhou, Y., Hu, Y., & Wang, T. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-024-01267-2 · Cited by 15
“In recent years, degenerative changes in motor neurons along the axons [3] and at the neuromuscular junctions (NMJs) (the specialized connections between motor neurons and muscles) [4], have been identified as prognostic indicators of ALS.”
AAV-NRIP gene therapy ameliorates motor neuron degeneration and muscle atrophy in ALS model mice
Chen, H.-H., Yeo, H.-T., Huang, Y.-H., Tsai, L.-K., Lai, H.-J., Tsao, Y.-P., & Chen, S.-L. (2024) · Skeletal Muscle · doi:10.1186/s13395-024-00349-z · Cited by 14
“NMJ degeneration is reported to occur in the early stages of ALS and persists throughout its progression [32, 46].”
BackgroundMcMacken, G., Whittaker, R. G., Wake, R., Lochmüller, H., & Horváth, R. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11643-z · Cited by 14
The Cellular and Molecular Signature of ALS in Muscle
Anakor, E., Duddy, W. J., & Duguez, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111868 · Cited by 15
“The neuromuscular junction (NMJ) represents a crucial site allowing bidirectional communication between the MN, muscle fibers, and terminal Schwann cells [34,35].”
BackgroundAmorós, M. A., Choi, E. S., Cofré, A. H. R., Dokholyan, N. V., & Duzzioni, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.962881 · Cited by 13
“NMJs are highly relevant for ALS, as its structural disassembly, and muscle denervation are both hallmarks of the disease (Cappello and Francolini, 2017).”
BackgroundZhang, D., Zhao, Y., Yan, C., Cao, L., & Li, W. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04027-7 · Cited by 11
Martínez, P., Silva, M., Abarzúa, S., Tevy, M. F., Jaimovich, E., Constantine‐Paton, M., Bustos, F. J., & van Zundert, B. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00942-4 · Cited by 14
Quigley, S., Quigg, K. H., & Goutman, S. A. (2025) · CNS Drugs · doi:10.1007/s40263-025-01217-0 · Cited by 11
“Dysregulation of TSCs in ALS is thought to lead to impaired and erroneous NMJ recovery and plasticity [290].”
The Molecular Architecture of Neurodegeneration: An Integrative Overview of Convergent Mechanisms
Aranda-Abreu, G. E., Rojas-Durán, F., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., Tlapa-Monge, L. R., & Mestizo-Gutiérrez, S. L. (2026) · NeuroSci · doi:10.3390/neurosci7010007 · Cited by 13
“In ALS, glutamate reuptake impairment by astrocytes and axonal damage reduces effective transmission at neuromuscular junctions [119].”
Chakravorty, A., Sharma, A., Sheeba, V., & Manjithaya, R. R. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.842772 · Cited by 8
“It is known that morphological changes in the NMJs are often correlated with functional defects as well, which might lead to behavioral deficits (Sleigh et al., 2014; Cappello and Francolini, 2017).”
BackgroundLiu, H., Guan, L., Deng, M., Bolund, L., Kristiansen, K., Zhang, J., Luo, Y., & Zhang, Z. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1116087 · Cited by 10
“, 2022), however, the disruption of the neuromuscular junction is an early event in ALS pathology (Cappello and Francolini, 2017).”
BackgroundTing, H.-C., Guo, Y., Su, H.-L., Chen, Y.-S., Lin, S., Harn, H., & Chang, C.-Y. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02302-5 · Cited by 10
Pasniceanu, I.-S., Atwal, M. S., Souza, C. D. S., Ferraiuolo, L., & Livesey, M. R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.784833 · Cited by 8
“, 1993) that is observed primarily, and more aggressively, in association with neuromuscular junctions innervated by fast-twitch motor neurons in SOD1G93A mice (Cappello and Francolini, 2017).”
BackgroundAutologous treatment for ALS with implication for broad neuroprotection
Kim, D.-H., Kim, S., Sung, A., Patel, N., Wong, N., Conboy, M. J., & Conboy, I. M. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00290-5 · Cited by 8
Bauer, U. S., Fiskum, V., Nair, R. R., van de Wijdeven, R., Kentros, C. G., Sandvig, I., & Sandvig, A. (2022) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2022.855071 · Cited by 7
Gazzola, M., & Martinat, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015291 · Cited by 8
“The consequences of these mutations on the NMJ have been investigated in different animal models (for a recent review, see [63]).”
BackgroundDeficient Sarcolemma Repair in ALS: A Novel Mechanism with Therapeutic Potential
Li, A., Yi, J., Li, X., Dong, L., Ostrow, L. W., Ma, J., & Zhou, J. (2022) · Cells · doi:10.3390/cells11203263 · Cited by 5
Leveraging Biomaterial Platforms to Study Aging-Related Neural and Muscular Degeneration
Hidalgo‐Alvarez, V., & Madl, C. M. (2024) · Biomolecules · doi:10.3390/biom14010069 · Cited by 5
“Furthermore, aging is a major risk This disorder leads to muscle weakness and atrophy, gradual paralysis, and respiratory failure [23].”
BackgroundMukhamedyarov, M. A., Grigoryev, P. N., Khisamieva, G. A., Khabibrakhmanov, A. N., Asgatovna, U. E., & Zefirov, A. L. (2019) · BioNanoScience · doi:10.1007/s12668-018-0590-8 · Cited by 5
Mechanistic insights of molecular chaperone Hsp70: Pathogenesis of neurodegenerative diseases
Choudhary, A., Kumar, P., Jagtap, Y. A., Kinger, S., Jha, H. C., Gutti, R. K., Sharma, V., Prajapati, V. K., & Mishra, A. (2025) · Brain Network Disorders · doi:10.1016/j.bnd.2025.05.001 · Cited by 6
The Effect of Skeletal Muscle-Specific Creatine Treatment on ALS NMJ Integrity and Function
Badu-Mensah, A., Guo, X., Mendez, R., Parsaud, H., & Hickman, J. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713519 · Cited by 5
“The first parameter evaluated was NMJ formation as NMJ regeneration and maintenance are known to be impaired in ALS [6].”
BackgroundMethodInfluentialPlum modulates Myoglianin and regulates synaptic function in D. melanogaster
Sahota, V. K., Stone, A., Woodling, N. S., Spiers, J. G., Steinert, J. R., Partridge, L., & Augustin, H. (2023) · Open Biology · doi:10.1098/rsob.230171 · Cited by 3
Berthiaume, A., Reda, S. M., Kleist, K. N., Setti, S. E., Wu, W., Johnston, J. L., Taylor, R. W., Stein, L. R., Moebius, H. J., & Church, K. J. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1348157 · Cited by 7
“…to assess nervous system tissues beyond the sciatic nerve, including brain and spinal cord, to gain a specific understanding of the treatment effects of ATH-1105 on upper and lower motor neurons, as well as on NMJs and the muscles themselves (Kiernan et al., 2011; Cappello and Francolini, 2017).”
BackgroundHibernation as a model for skeletal muscle preservation
Porczak, A. E., & Feng, N. Y. (2025) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.15389 · Cited by 3
“34,35 In MG, autoimmune attacks target presynaptic voltage-gated Ca 2 + channels, causing decreased ACh release and reduced signaling efficiency.”
Arnaldi, P., Casarotto, E., Relucenti, M., Bellese, G., Gagliani, M. C., Crippa, V., Castagnola, P., & Cortese, K. (2024) · Microscopy Research and Technique · doi:10.1002/jemt.24651 · Cited by 3
“In amyotrophic lateral sclerosis (ALS), skeletal muscle denervation leads to atrophy and eventual fatality (Cappello & Francolini, 2017).”
Li, A., Yi, J., Li, X., Dong, L., Ostrow, L. W., Ma, J., & Zhou, J. (2023) · eLife · doi:10.7554/elife.92644 · Cited by 3
“The "en plaque" type of NMJs are located in the middle portion of myofibers and resemble NMJs seen in other types of muscles.”
BackgroundMakanae, Y., Ato, S., Kouzaki, K., Tamura, Y., & Nakazato, K. (2024) · Experimental Physiology · doi:10.1113/ep091006 · Cited by 4
Bolatto, C., Olivera‐Bravo, S., & Cerri, S. (2021) · Journal of Visualized Experiments · doi:10.3791/62620 · Cited by 3
Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis
Maes, K. J. H., & Briedé, J. J. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150032 · Cited by 6
Maskell, K. G., Cook, A. L., King, A. E., Dickson, T. C., & Blizzard, C. L. (2026) · Lab on a Chip · doi:10.1039/d5lc00577a · Cited by 3
Review of the Pathology of Muscle in Amyotrophic Lateral Sclerosis
Katz, M., Robertson, T., Ngo, S. T., Yarlagadda, S., Henderson, R. D., McCombe, P., & Noakes, P. G. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062802 · Cited by 2
“However, when biopsies are performed at the site of motor endplates, denervation and disassembly of the NMJ can be observed [18,96,195].”
Stansberry, W. M., Fiur, N. C., Robins, M. M., & Pierchala, B. A. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1491415 · Cited by 3
Baskoylu, S., Chapkis, N., Unsal, B., Lins, J., Schuch, K. N., Simon, J., & Hart, A. C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/799932 · Cited by 2
“Knock-in animals have impaired neuromuscular function Neuromuscular dysfunction precedes motor neuron degeneration in ALS patient motor neurons [37–39].”
BackgroundLi, A., Yi, J., Li, X., Dong, L., Ostrow, L. W., Ma, J., & Zhou, J. (2023) · eLife · doi:10.1101/2023.02.12.528218 · Cited by 12
Martínez, P., Silva, M., Abarzúa, S., Tevy, M. F., Jaimovich, E., Constantine‐Paton, M., Bustos, F. J., & van Zundert, B. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.24.595817 · Cited by 2
“…nervous system (CNS) are also affected in ALS, including lymphocytes (Cova et al., 2006), fibroblasts (Aguirre et al., 1998), and skeletal muscle (Cappello & Francolini, 2017; Dobrowolny et al., 2008; Frey et al., 2000; W. Guo et al., 2020; Hegedus et al., 2007; Jensen et al., 2016; Wong &…”
BackgroundHossain, M. F., Popsuj, S., Vitrinel, B., Kaplan, N., Stolfi, A., Christiaen, L., & Ruggiu, M. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003392 · Cited by 2
Therapeutic horizons of MuSK in amyotrophic lateral sclerosis: a comprehensive narrative review
Gautam, P., Vishwakarma, R. K., Kumar, D., & Pathak, A. (2026) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-026-01083-7 · Cited by 1
“Unlike MG, ALS pathology does not involve autoantibodies against AChR, MuSK, or titin, suggesting a distinct molecular basis [15, 18, 33, 36].”
Banerjee, S., Panjwani, D., Singh, S., & Singh, T. G. (2026) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2026.578942 · Cited by 1
Roles and therapeutic prospects of the laminin family in disorders of the nervous system
Zhang, X., Li, X., Gao, L., Qiao, Y., Lv, B., Zhang, Q. D., Zhang, M., Yu, J., Li, H., Bi, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08410-9 · Cited by 2
“Clinically and in models, NMJ morphological abnormalities can emerge early in ALS [248], whereas extraocular muscles (EOM) are relatively “spared” in many patients [249]; their distinctive BM laminin isoform repertoire and signaling milieu may confer resistance to denervation, suggesting that…”
Ragunathan, S., Bell, L. C., Semmineh, N. B., Stokes, A. M., Shefner, J. M., Bowser, R. P., Ladha, S. S., & Quarles, C. C. (2021) · Tomography · doi:10.3390/tomography7020015 · Cited by 1
“Although current literature on motor neuron dysfunction in ALS is extensive, there is a continuing debate about whether motor neuron death is of a forward (UMN spreading to LMN) or backward (LMN spreading to UMN) nature [3].”
BackgroundSubraman, T., & Sujatha, S. N. N. (2018) · International Journal of Engineering & Technology · doi:10.14419/ijet.v7i3.10.15641
Plum is a novel regulator of synaptic function and muscle size in D. melanogasterPreprint
Augustin, H., Spiers, J. G., Woodling, N. S., Steinert, J. R., & Partridge, L. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/463885
“…motoneuronal and neuromuscular disorders, with impaired neurotransmission and muscle wasting characterising amyotrophic lateral sclerosis (ALS) (Cappello and Francolini, 2017; Chand et al., 2018; Pansarasa et al., 2014), myotonic and muscular dystrophies (Bombelli et al., 2016; Malatesta,…”
BackgroundA Co-culture System of C2C12 and MN1 for Neuromuscular Junction (NMJ)
Zhang, X. (2020) · University of Minnesota Digital Conservancy (University of Minnesota)
Sarcopenia in neurodegenerative disorders
Korotysh, M. A., Svetozarskiy, S. N., & Kopishinskaia, S. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-36-52-57
Effect of 3,4-diaminopyridine phosphate in symptomatic SOD1-G93A mice
Ramaswamy, S. B., Stanford, J. A., Iyadurai, S. J. P., Govindarajan, R., & Barohn, R. J. (2022) · RRNMF Neuromuscular Journal · doi:10.17161/rrnmf.v2i5.15641
Metadata
- Authors
- Cappello, V., & Francolini, M.
- Affiliations
- Italian Institute of Technology (IT)
- University of Milan (IT)
- Corresponding author
- Cappello, Valentina
- Francolini, Maura
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-03
- Volume
- 18
- Issue
- 10
- Pages
- 2092
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5666774
- OpenAlex
- W2761206394
- Cited by
- 119
- References
- 117
- Citations by year
- 2026: 13 · 2025: 11 · 2024: 19 · 2023: 14 · 2022: 18 · 2021: 17 · 2020: 8 · 2019: 13 · 2018: 6
- FWCI
- 0.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- amyotrophic lateral sclerosis, muscle denervation, motor neuron degeneration, glial cells, synaptic plasticity, skeletal muscle atrophy
- MeSH terms
- Aging, Amyotrophic Lateral Sclerosis, Animals, Humans, Motor Neurons, Neuroglia, Neuromuscular Junction, Schwann Cells, Synapses, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.